We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SARO
226
StandardAero Inc
SARO
$9.96B
| $26.1M | 0.14% |
825,695
+170,142
| +26% | +$4.77M |
|
227
Outset Medical
OM
$92.5M
| $25.5M | 0.13% |
1,325,784
| – | – |
|
228
Warrior Met Coal
HCC
$4.25B
| $25.4M | 0.13% |
554,667
-340,271
| -38% | -$15.8M |
|
229
Xylem
XYL
$27.8B
| $25.4M | 0.13% |
196,308
+185,539
| +1,723% | +$22.5M |
|
230
GE Aerospace
GE
$383B
| $25.3M | 0.13% |
98,460
+37,734
| +62% | +$8.28M |
|
|
DNB
231
DELISTED
Dun & Bradstreet
DNB
| $25.1M | 0.13% |
2,760,000
+42,900
| +2% | +$384K |
|
232
Insmed
INSM
$21.3B
| $25.1M | 0.13% |
248,921
+151
| +0.1% | +$11.5K |
|
233
Westlake Corp
WLK
$8.95B
| $24.9M | 0.13% |
+327,290
| New | +$26.8M |
|
234
Coherent
COHR
$56.4B
| $24.8M | 0.13% |
277,839
-82,562
| -23% | -$5.94M |
|
235
Canadian Pacific Kansas City
CP
$79.7B
| $24.4M | 0.13% |
307,426
+107,597
| +54% | +$8.28M |
|
236
Supernus Pharmaceuticals
SUPN
$2.67B
| $24.4M | 0.13% |
+772,976
| New | +$24.8M |
|
237
Carrier Global
CARR
$52.1B
| $24.3M | 0.13% |
+331,423
| New | +$22.5M |
|
238
ServiceNow
NOW
$118B
| $24.1M | 0.13% |
117,300
+28,530
| +32% | +$5.38M |
|
239
Walt Disney
DIS
$170B
| $24.1M | 0.13% |
194,461
-327,665
| -63% | -$34M |
|
240
Cognizant
CTSH
$24.9B
| $24.1M | 0.13% |
+308,451
| New | +$23.6M |
|
241
Immunovant
IMVT
$7.91B
| $24M | 0.13% |
1,498,725
+856
| +0.1% | +$12.9K |
|
242
GlobalFoundries
GFS
$27.4B
| $24M | 0.13% |
627,683
-280,048
| -31% | -$10.2M |
|
243
Suncor Energy
SU
$77.9B
| $23.9M | 0.13% |
+638,881
| New | +$23.1M |
|
244
Reddit
RDDT
$29.8B
| $23.9M | 0.13% |
158,605
+65,797
| +71% | +$7.46M |
|
245
Diamondback Energy
FANG
$55.9B
| $23.8M | 0.13% |
+173,388
| New | +$24M |
|
246
Goldman Sachs
GS
$303B
| $23.5M | 0.12% |
33,191
+6,828
| +26% | +$3.96M |
|
247
Estee Lauder
EL
$30.6B
| $23.4M | 0.12% |
289,432
+50,018
| +21% | +$3.22M |
|
|
CON
248
Concentra Group Holdings
CON
$4.06B
| $23.3M | 0.12% |
1,131,517
+139,829
| +14% | +$2.99M |
|
249
Century Aluminum
CENX
$4.47B
| $23.2M | 0.12% |
1,289,491
+248,679
| +24% | +$4.22M |
|
250
Steel Dynamics
STLD
$37B
| $22.8M | 0.12% |
177,857
+30,049
| +20% | +$3.84M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.